BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14762867)

  • 1. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
    Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E
    Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
    Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
    Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
    Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
    Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
    Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival.
    Massicotte L; Denault AY; Beaulieu D; Thibeault L; Hevesi Z; Roy A
    Transplantation; 2011 Jun; 91(11):1273-8. PubMed ID: 21617589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A; Aşik R; Atahan E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolytic inhibitors and prevention of bleeding in cardiac valve surgery. Comparison of tranexamic acid and high dose aprotinin].
    Boughenou F; Madi-Jebara S; Massonnet-Castel S; Benmosbah L; Carpentier A; Cousin MT
    Arch Mal Coeur Vaiss; 1995 Mar; 88(3):363-70. PubMed ID: 7487290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation.
    Kaspar M; Ramsay MA; Nguyen AT; Cogswell M; Hurst G; Ramsay KJ
    Anesth Analg; 1997 Aug; 85(2):281-5. PubMed ID: 9249100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.